PERITONEAL DIALYSIS TECHNIQUE SURVIVAL: A SINGLE-CENTER EXPERIENCE ANALYSIS OF THE PERITONEAL DIALYSIS TREATMENT IN A SINGLE CENTER
Abstract
The aim of the study was to evaluate retrospectively the survival of the peritoneal dialysis (PD) technique survival and identify the factors that affect it.
Patients and methods. A total of 38 patients with end-stage renal disease treated with PD from 2005 to May 2017 have been included in retrospective, study (average age 49.6 ± 5.6). Data were collected from medical records.
Results. The average survival rate of the PD method in our center was 53.3 ± 7.4 months, and in patients with nondiabetic kidney disease it was significantly higher. During the follow-up only 11/38 (28.9 %) patients continue treatment of PD, 12/38 (31.6 %) were changed to HD, 4/38 (10.6 %) patients kidney transplantation was performed and 11/38 %) died. The main reason of the letal cases was cardiovascular complications (36.6 %). The patient mortality was significantly depended on the diuresis volume and the level of GFR at the time of PD initiation.
Conclusions. PD technique survival in our center correlate with the results of the PD treatment patients worldwide.
Downloads
References
Андрусев А. М. Перитонеальный диализ: отдаленные результаты лечения, факторы, их определяющие, и клиническая патофизиология метода / А. М. Андрусев // Нефрология и диализ. – 2005. – Т. 7. – № 2. – С. 110–129.
Національний реєстр хворих на хронічну хворобу нирок та пацієнтів з гострим пошкодженням нирок: 2015 рік / уклад. Н. І. Козлюк [та ін.]; Академія медичних наук України, Міністерство охорони здоров’я України, Державна установа «Інститут нефрології НАМН України»; гол. ред. М. О. Колесник. – К., 2016. – 200 с. – 40 прим.
Реброва О. Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ STATISTICA / О. Ю. Реброва. – М. : Медиа сфера, 2003. – 312 с.
Churchill D.N. (CANUSA) Peritoneal Dialysis Study Group: Lower probability of survival with continuous peritoneal dialysis in the United States compared with Canada / Churchill D.N., Thorpe K.E., Vonesh E.F., Keshaviah P.R. // J Am. Soc. Nephrol. – 2001. – V. 8. – P. 965-971.
Garosi G. Encapsulating peritoneal sclerosis / Garosi G1, Mancianti N, Corciulo R, La Milia V, Virga G // J. Nephrol. – 2013. – V. 26 (21). – P. 177-187.
Marrón B. Benefits of preserving residual renal function in peritoneal dialysis / Marrón B., Remón C., Pérez-Fontán M., Quirós P., Ortíz A // Kidney Int. – 2008. – V. 108. – P. 42-51.
Martín-Cleary C. CKD hotspots around the world: where, why and what the lessons are. A CKJ review series / Mart n-Cleary C, Ortiz A //. Clin Kidney J. 2014. – Dec. 7(6). – P. 519-523.
Molecular Mechanisms Underlying Peritoneal EMT and Fibrosis (Electronic resource) / Raffaele Strippoli, Roberto Moreno-Vicente, [et al.] // Stem Cells International. – V. 2016. – Mode of access: http://www.hindawi.com/journals/sci/2016/3543678/
KawaguchiY. Peritoneal dialysis as long-term treatment: comparison of technique survival between asian and western populations. Perit. Dial. Int. – 1999. – V. – 19(2). – P. 327-328.
Kaysen G.A. Prokinetic agents in crease plasma albumin in hypoalbuminemic chronic dialysis patients with delayed gastric emptying / Kaysen G.A., Silang R., Regalado M., Cheng T.H., Wesson D.E. // AmJ. Kidney Dis. – 2001. – V. 37(2). – P. 287- 293.
Kolesnyk I. Time-dependent reasons for peritoneal dialysis technique failure and mortality / Kolesnyk I., Friedo W. Dekker, Elisabeth W., [et al.] // Perit. Dial. Int. – 2010. – V. 30 (2). – P. 170-177.
Krediet R.T. Neoangiogenesis in the peritoneal membrane / KredietR.T., Zweers M. M., Vander W., Struijk D.G // Perit. Dial. Int. – 2000. – V. – 20 (2). – P. 19-25.
Ronco C. Adequacy of peritoneal dialysis is more than Kt/V / Ronco C // Nephrol Dial Transplant. – 1997. – Vol.12 (1). – P. 68-73.
